Globalisation on pause? How scaleups can navigate today's uncertainty9:30 am - 10:30 am
BGF backs multi-channel retailer Revital
BGF has made a significant minority investment in London-based Revital, a multi-channel retailer of supplements, beauty and wellness products.
Founded in 1991 by Raj Vora, the family business is now under the stewardship of his son, chief executive Rahil Vora. Revital sells branded and own-brand products across a range of categories including; vitamins and supplements, food & drink, beauty and lifestyle.
Revital is now an established, premium brand in the health and wellness sector, with 18 sites across the South East of England. The company’s customer service focus includes employing nutritional experts in every store.
The business will use the funding to invest in its online channel, new product development and continued rollout of stores, in addition to supporting key hires within the team.
Alongside BGF’s investment, Jeremy Seigal has joined the board as non-executive Chairman to support the company’s expansion. Jeremy has recently stepped down after five years as CEO of White Stuff. He set up and ran The Perfume Shop before selling it to AS Watson (Health and Beauty) where he assumed the CEO role.
Rahil Vora, CEO, Revital said: “The health and wellness category continues to present a huge opportunity for Revital. As a family business, we wanted to remain in control as we scale the company. BGF’s approach provides us with a minority investment partner who can stay with the business as we expand.”
Jon Simon, BGF said: “Revital provides an exciting opportunity to invest in a premium health and wellness retailer, operating in a high-growth market, which reflects changing consumer lifestyles. We’re pleased to be supporting Rahil and Raj as they further develop the brand and multi-channel offering.”
Business funding news
OSL receives £3.5 million follow-on investment as impressive growth continues
BGF has invested a further £3.5 million into leading counter-drone technologies business Operational Solutions Limited (OSL), taking its total investment…
ViaNautis raises £20 million Series A financing to drive the next generation of genetic nanomedicines
ViaNautis Bio, a ground-breaking nanomedicine company at the forefront of genetic therapies, has completed its Series A funding round, raising…